Publications

Published in Top 10% journals in the field

ALBERTO, S., A. ORDONEZ, C. ARJUN, C. ARJUN, G. AULAKH, N. BEZIERE, E. DADACHOVA, T. EBENHAN, U. GRANADOS, A. KORDE, J. AMIRREZA, W. LESTARI, A. MUKHERJEE, M. PETŘÍK, T. SAKR, C. SANTOS CUEVAS, M. WELLING, J. ZEEVAART, S. JAIN, D. WILSON
The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. Journal of Nuclear Medicine. 2023, ISSN: 0161-5505, PMID: 37770110.
PATIL, P., Q. ZHENG, K. KURPIEWSKA, A. DÖMLING
The isocyanide SN2 reaction. Nature Communications. 2023, 14(1), 5807, ISSN: 2041-1723, PMID: 37726293,  PDF.
LOFFELMANN, M., Z. ŠKROTT, D. MAJERA, P. STARHA, V. KRYŠTOF, M. MISTRÍK
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells. European Journal of Medicinal Chemistry. 2023, 261, 115790, ISSN: 0223-5234 , PMID: 37690264,
WAZYNSKA, M., R. BUTERA, M. REQUESENS, A. PLAT, T. ZARGANES-TZITZIKAS, C. NEOCHORITIS, J. PLEWKA, L. SKALNIAK, J. KOCIK-KROL, B. MUSIELAK, K. MAGIERA-MULARZ, I. RODRIGUEZ, S. BLOK, M. DE BRYUN, H. NIJMAN, P. ELSINGA, T. HOLAK, A. DÖMLING
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644,
SHALDAM, M., D. HENDRYCHOVA, R. EL-HAGGAR, V. VOJÁČKOVÁ, T. MAJRASHI, E. ELKAEED, N. MASURIER, V. KRYŠTOF, H. TAWFIK, W. ELDEHNA
2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 2023, 258, 115610, ISSN: 0223-5234, PMID: 37437350,
DVOŘÁKOVÁ BENDOVÁ, K., V. RACLAVSKÝ, R. NOVOTNY, D. LUPTAKOVA, M. POPPER, Z. NOVÝ, M. HAJDÚCH, M. PETŘÍK
[68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography. Journal of Medicinal Chemistry. 2023, ISSN: 0022-2623, PMID: 37252893,
DAS, V., M. HAJDÚCH
Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants. Brain. 2023, ISSN: 0006-8950, PMID: 37243427,
KANELLIS, D., A. ZISI, Z. ŠKROTT, B. LEMMENS, J. ESPINOZA, M. KOSAR, A. BJÖRKMAN, X. LI, S. ARAMPATZIS, J. BARTKOVA, M. ANDUJAR-SANCHEZ, O. FERNANDEZ-CAPETILLO, M. MISTRÍK, M. LINDSTROM, J. BÁRTEK
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death and Differentiation. 2023, ISSN: 1350-9047, PMID: 37142656,
BUCHTOVÁ, T., L. BÉRESOVÁ, K. CHROMÁ, T. PLUHACEK, T. BERES, D. KACZOROVA, P. TARKOWSKI, J. BÁRTEK, M. MISTRÍK
Cannabis-derived products antagonize platinum drugs by altered cellular transport. Biomedicine & Pharmacotherapy. 2023, 163, 114801, ISSN: 0753-3322, PMID: 37137184,
IVASECHKO, I., A. LOZYNSKYI, J. SENKIV, P. ROSZCZENKO, Y. KOZAK, N. FINIUK, O. KLYUCHIVSKA, N. KASHCHAK, N. MANKO, Z. MASLYAK, D. LESYK, A. KARKHUT, S. POLOKVOVYCH, R. CZARNOMYSY, O. SZEWCZYK, A. KOZYTSKIY, O. KARPENKO, D. KHYLUK, A. GZELLA, K. BIELAWSKI, A. BIELAWSKA, P. DŽUBÁK, S. GURSKÁ, M. HAJDÚCH, R. STOIKA, R. LESYK
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone). European Journal of Medicinal Chemistry. 2023, 252, 115304, ISSN: 0223-5234, PMID: 37001390,  PDF.